Results 191 to 200 of about 29,486 (214)

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study. [PDF]

EClinicalMedicine
Garrett N, Tapley A, Hudson A, Dadabhai S, Zhang B, Mgodi NM, Andriesen J, Takalani A, Fisher LH, Kee JJ, Magaret CA, Villaran M, Hural J, Andersen-Nissen E, Ferarri G, Miner MD, Le Roux B, Wilkinson E, Lessells R, de Oliveira T, Odhiambo J, Shah P, Polakowski L, Yacovone M, Samandari T, Chirenje Z, Elyanu PJ, Makhema J, Kamuti E, Nuwagaba-Biribonwoha H, Badal-Faesen S, Brumskine W, Coetzer S, Dawson R, Delany-Moretlwe S, Diacon AH, Fry S, Gill KM, Ebrahim Hoosain ZA, Hosseinipour MC, Inambao M, Innes C, Innes S, Kalonji D, Kasaro M, Kassim P, Kayange N, Kilembe W, Laher F, Malahleha M, Maluleke VL, Mboya G, McHarry K, Mitha E, Mngadi K, Mda P, Moloantoa T, Mutuluuza CK, Naicker N, Naicker V, Nana A, Nanvubya A, Nchabeleng M, Otieno W, Potgieter EL, Potloane D, Punt Z, Said J, Singh Y, Tayob MS, Vahed Y, Wabwire DO, McElrath MJ, Kublin JG, Bekker LG, Gilbert PB, Corey L, Gray GE, Huang Y, Kotze P, CoVPN 3008 Ubuntu Study Team.   +80 more
europepmc   +1 more source

Letter to the Editor Regarding: "Real-World Effectiveness of a Third Dose of mRNA-1273 Versus BNT162b2 on Inpatient and Medically Attended COVID-19 Among Immunocompromised US Adults". [PDF]

Infect Dis Ther
Daungsupawong H, Wiwanitkit V.
europepmc   +1 more source

Real-World Effectiveness of COVID-19 Vaccines (ChAdOx-1s, CoronaVac, BBIBP-CorV, mRNA-1273, and BNT162b2) in Jakarta: Protocol for Test-Negative Design of Health Care Data.

JMIR Res Protoc
Burhan E, Azzumar F, Sinuraya FAG, Rakasiwi MID, Akbar I, Mubarak F, Rengganis AT, Rachmadi RA, Afidjati H.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

New England Journal of Medicine, 2021
Hana M El Sahly, David J Diemert, C Buddy Creech   +2 more
exaly  

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

New England Journal of Medicine, 2021
Alicia T Widge, Nadine G Rouphael, Lisa A Jackson   +2 more
exaly  

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19

New England Journal of Medicine, 2021
Nicole A Doria-Rose, Adrian B Mcdermott, John R Mascola   +2 more
exaly  

mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron

Cell, 2022
Matthew Gagne, Kathryn E Foulds, Anne P Werner   +2 more
exaly